NCT06776926

Timing of Carbetocin Administration in Postpartum Hemorrhage

When Should Carbetocin be Administered to Prevent Postpartum Hemorrhage After Normal Vaginal Delivery?

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (actual)
• Sponsor: Mehmet Mete Kırlangıç · Other Government
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Postpartum haemorrhage (PPH) is one of the major contributors to maternal mortality and morbidity worldwide. Active management of the third stage of labour has been proven to be effective in the prevention of PPH. Syntometrine is more effective than oxytocin but is associated with more side effects. Carbetocin, a long-acting oxytocin agonist, appears to be a promising agent for the prevention of PPH. The use of carbetocin, being an important agent in the prevention of PPH, also increases its prevalence. It is planned to investigate the advantages and disadvantages of the timing of its use.

Conditions

• Postpartum Hemorrhage
• Carbetocin

Interventions

Type	Name	Description
BEHAVIORAL	Carbetocin	Use of carbetocin

Timeline

• Start date: 2025-01-10
• Primary completion: 2025-02-28
• Completion: 2025-02-28
• First posted: 2025-01-15
• Last updated: 2025-09-18

Locations

1 site across 1 country: Turkey (Türkiye)